C-Suite Advisory

C-Suite Advisory

Los Angeles Lakers are inviting Mike Brown to coach Kobe Bryant and replace Phil Jackson?

About a year ago, the Cleveland Cavaliers fired Mike Brown because they didn't think he was good enough to coach LeBron James now he will coach Kobe Bryant, reportedly is four years, $18 million. Phil Jackson retired after the team’s loss to Dallas in the second round of the playoffs....
C-Suite Advisory

CEOWORLD ETF’s Watch List for 04/28- TZA, VXX, GLD, TNA, QID, QQQ, QLD, MDY, SPY, SSO, SRS

Direxion Small Cap Bear 3X Shares (ETF) (NYSE:TZA)- The Fund’s objective is daily investment results, before fees and expenses, of 300% of the inverse of the price performance of the Small Cap Index. The Fund invests in at least 80% of its net assets in Financial Instruments that, provide exposure to the Small Cap Index. iPath S&P 500 VIX Short-Term Futures ETN (NYSE:VXX)- iPATH S&P 500 VIX Short-Term Futures ETN is currently below its 50-day moving average of $30.33 and below its 200-day moving average of $51.69
C-Suite Advisory

CEOWORLD Top 5 Analyst Calls of the Week- DNDN, INSP, MCP, SIRI, VICL

Dendreon Corporation (NASDAQ: DNDN)- Dendreon Corporation (Dendreon) is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. The Company’s product portfolio includes active cellular immunotherapy and small molecule product candidates to treat a range of cancers. Its advanced product candidate is Provenge (sipuleucel-T), an active cellular immunotherapy that has completed three Phase III trials for the treatment of metastatic, castrate-resistant, (also known as androgen-independent or hormone-refractory) prostate cancer.
1 182 183 184 185 186 191
Page 184 of 191